The present invention provides a novel fusion polypeptide containing a catalytic portion of NPP1 fused to a targeting moiety, nucleic acids encoding the fusion polypeptide, a vector containing the nucleic acid integrated thereinto, a host cell transformed with the vector and pharmaceutical compositions comprising the fusion polypeptide.
申请公布号
WO2011113027(A2)
申请公布日期
2011.09.15
申请号
WO2011US28233
申请日期
2011.03.11
申请人
SYNAGEVA BIOPHARMA CORP;QUINN, ANTHONY;HARVEY, ALEX J.;XIA, ZHINAN